Search

Your search keyword '"Guaifenesin chemistry"' showing total 47 results

Search Constraints

Start Over You searched for: Descriptor "Guaifenesin chemistry" Remove constraint Descriptor: "Guaifenesin chemistry"
47 results on '"Guaifenesin chemistry"'

Search Results

1. Optimal performance comparison of the simulated moving bed process variants based on the modulation of the length of zones and the feed concentration.

2. Physicochemical Evaluation of Compounded Oral Preparations for Respiratory Illnesses, also known as Mezclitas.

3. Theoretical study on the microscopic mechanism of lignin solubilization in Keggin-type polyoxometalate ionic liquids.

4. Synthesis of a novel magnetic starch-alginic acid-based biomaterial for drug delivery.

5. Simultaneous Quantification of Chlorpheniramine, Phenylephrine, Guaifenesin in Presence of Preservatives with Detection of Related Substance Guaiacol in their Cough Syrup by RP-HPLC and TLC-Densitometric Methods.

6. Bitterless guaifenesin prodrugs-design, synthesis, characterization, in vitro kinetics, and bitterness studies.

7. HPTLC-Densitometric Method for Determination of Ascorbic Acid, Paracetamol and Guaifenesin in Presence of Their Toxic Impurities.

8. Selective Determination of Levodopa in the Presence of Vitamin B 6 , Theophylline and Guaifenesin Using a Glassy Carbon Electrode Modified with a Composite of Hematoxylin and Graphene/ZnO.

9. Enantioseparation of racemic aminoglutethimide using asynchronous simulated moving bed chromatography.

10. Dissolution Testing for Bioavailability of Over-the-Counter (OTC) Drugs--a Technical Note.

11. Determining the suitability of mass spectrometry for understanding the dissolution processes involved with pharmaceutical tablets.

12. Vibrational spectra of guaiacylglycerol-β-guaiacyl ether: experiment and theory.

13. Ternary metal complexes of guaifenesin drug: Synthesis, spectroscopic characterization and in vitro anticancer activity of the metal complexes.

14. Experiment and modeling for the separation of guaifenesin enantiomers using simulated moving bed and Varicol units.

15. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.

16. Novel stereoselective high-performance liquid chromatographic method for simultaneous determination of guaifenesin and ketorolac enantiomers in human plasma.

17. Desktop 3D printing of controlled release pharmaceutical bilayer tablets.

18. Characterization of the binding of metoprolol tartrate and guaifenesin drugs to human serum albumin and human hemoglobin proteins by fluorescence and circular dichroism spectroscopy.

19. Application of hollow fiber-supported liquid-phase microextraction coupled with HPLC for the determination of guaifenesin enantiomer-protein binding.

20. Using dispersive liquid-liquid microextraction and liquid chromatography for determination of guaifenesin enantiomers in human urine.

21. Modulating the synthetase activity of penicillin G acylase in organic media by addition of N-methylimidazole: using vinyl acetate as activated acyl donor.

22. A new technique for spectrophotometric determination of pseudoephedrine and guaifenesin in syrup and synthetic mixture.

23. Simultaneous determination of potassium guaiacolsulfonate, guaifenesin, diphenhydramine HCl and carbetapentane citrate in syrups by using HPLC-DAD coupled with partial least squares multivariate calibration.

24. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.

25. A sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma---application to pharmacokinetic and bioequivalence studies.

26. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.

27. Implementation of an automated on-line high-performance liquid chromatography monitoring system for 'cycle to cycle' control of simulated moving beds.

28. Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis.

29. Disassembly of lignin and chemical recovery in supercritical water and p-cresol mixture. Studies on lignin model compounds.

30. Experimental implementation of automatic 'cycle to cycle' control of a chiral simulated moving bed separation.

31. Crystal growth formation in melt extrudates.

32. "Crystal dex:" free-base dextromethorphan.

33. Physicochemical properties of film-coated melt-extruded pellets.

34. Non-enzymatic reduction of quinone methides during oxidative coupling of monolignols: implications for the origin of benzyl structures in lignins.

35. Wood stimulates the demethoxylation of [O14CH3]-labeled lignin model compounds by the white-rot fungi Phanerochaete chrysosporium and Phlebia radiata.

36. Effects of incorporated drugs on degradation of novel 2,2'-bis(2-oxazoline) linked poly(lactic acid) films.

37. Beta-galactosidase catalyzed selective galactosylation of aromatic compounds.

38. The cellulose/lignin assembly assessed by molecular modeling. Part 1: adsorption of a threo guaiacyl beta-O-4 dimer onto a Ibeta cellulose whisker.

39. Effects of formulation variables and characterization of guaifenesin wax microspheres for controlled release.

40. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films.

41. Conformational study of a guaiacyl beta-O-4 lignin model compound by NMR. Examination of intramolecular hydrogen bonding interactions and conformational flexibility in solution.

42. Polymerization of guaiacol and a phenolic beta-O-4-substructure by Trametes hirsuta laccase in the presence of ABTS.

43. Detection and characterization of a novel extracellular fungal enzyme that catalyzes the specific and hydrolytic cleavage of lignin guaiacylglycerol beta-aryl ether linkages.

44. Solubility of guaifenesin in the presence of common pharmaceutical additives.

45. Guaiacylglycerol-7'-O-methyl 8'-vanillic acid ether and related compounds from Boreava orientalis.

46. Degradation of and drug release from a novel 2,2-bis(2-oxazoline) linked poly(lactic acid) polymer.

47. Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms.

Catalog

Books, media, physical & digital resources